Delivery Order SPE2DE24D0013-SPE2D625F2NKV
- Not listed
- The U.S. Defense Department's Medical Supply Chain organization awarded a $2,835 firm fixed-price delivery order to Cepheid Inc. on August 29, 2025, for molecular diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The delivery order, which extends through September 8, 2025, will be performed at Cepheid's facility in Sunnyvale, California. This award carries no small business set-aside designation and represents a continuation of...
- The U.S. Defense Medical Supply Chain awarded a $13.6K delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on September 2, 2025, with completion targeted for September 9, 2025. This firm fixed-price delivery order (Contract No. 4569302261) procures diagnostic testing capabilities for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a continuation of...
- This delivery order, awarded August 19, 2025, represents a firm fixed-price contract worth $8,160 for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The order was issued to Cepheid Inc., a Sunnyvale, California-based manufacturer specializing in advanced molecular diagnostic systems and reagents for infectious disease detection. Performance will take place at Cepheid's Sunnyvale facility, with an ultimate completion date of August...
- Cepheid Inc., a molecular diagnostic solutions manufacturer based in Sunnyvale, California, was awarded a firm fixed-price delivery order valued at $2,040 by the Defense Logistics Agency's Medical Supply Chain division on August 22, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, is scheduled for completion by August 29, 2025, and covers molecular diagnostic testing solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside...
- The U.S. Defense Department's Medical Supply Chain division awarded a $17,280 firm fixed-price delivery order to Cepheid Inc. on August 27, 2025, with an ultimate completion date of September 4, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus. Cepheid, a Sunnyvale, California-based manufacturer of advanced diagnostic systems and test kits, was selected without a set-aside...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- This delivery order, valued at $6,800, was awarded to Cepheid Inc. on July 28, 2025, for molecular diagnostic solutions related to COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing. The contract operates under a firm fixed-price structure with no set-aside designation and is funded by the Defense Department's Medical Supply Chain organization. Performance will take place at Cepheid's headquarters in Sunnyvale, California. This award is likely issued under one of Cepheid's...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $3,400 by the Defense Logistics Agency (a component of the Department of Defense) on August 4, 2025, with a completion date of August 11, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves firm fixed-price procurement of diagnostic testing solutions, specifically for COVID-19, influenza, and respiratory syncytial virus (RSV) detection capabilities. This...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Logistics Agency awarded a $12,240 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, with an ultimate completion date of August 15, 2025, was awarded on August 8, 2025, with no set-aside designation. Cepheid, a Sunnyvale, California-based manufacturer specializing in molecular diagnostic systems and test kits, will perform the work at its California...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2NKVDelivery Order
This delivery order, valued at $6,800, was awarded to Cepheid Inc. on September 4, 2025, by the Medical Supply Chain, a defense-focused federal agency. The contract covers molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) detection, with performance to be completed at Cepheid's Sunnyvale, California facility by September 11, 2025. The award carries a firm fixed-price structure with no set-aside designation, indicating competitive procurement. Cepheid is a specialized manufacturer of molecular diagnostic systems and test kits that has established significant relationships across federal healthcare agencies, including the Department of Veterans Affairs and Defense Logistics Agency. This delivery order likely represents a task issued under one of Cepheid's existing Indefinite Delivery Vehicle contracts, potentially the Veterans Integrated Service Network 21 IDV valued at $2.5 million, which specifically covers PCR testing for laboratory microbiology including COVID-19, influenza, and RSV diagnostics. The relatively modest ceiling value and compressed timeline suggest this represents a specific clinical testing need within the federal defense or veterans healthcare system. Cepheid's established track record in federal molecular diagnostics procurement, evidenced by their substantial IDV portfolio exceeding $35 million, positions the company as a key supplier for rapid diagnostic capabilities across federal healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.8k | 9/4/25 |